• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌适形放射治疗中患者对直肠气囊的耐受性

Patient tolerance of rectal balloons in conformal radiation treatment of prostate cancer.

作者信息

Ronson Brian B, Yonemoto Les T, Rossi Carl J, Slater James M, Slater Jerry D

机构信息

Department of Radiation Medicine, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1367-70. doi: 10.1016/j.ijrobp.2005.11.001. Epub 2006 Feb 20.

DOI:10.1016/j.ijrobp.2005.11.001
PMID:16488552
Abstract

PURPOSE

To evaluate patient tolerance of intrarectal balloons used during conformal prostate irradiation.

METHODS AND MATERIALS

A retrospective analysis was performed on 3,561 patients who underwent conformal radiation for prostate cancer. Therapy consisted of proton irradiation of the prostate and seminal vesicles and X-ray treatment of the pelvis when warranted. The number of treatments in which the balloon was tolerated was recorded. Results were stratified according to method of irradiation (protons alone vs. combined proton/X-ray) and method of planning (2D vs. 3D planning of X-ray fields in patients undergoing combination treatment).

RESULTS

Of all the patients evaluated, 3,474 (97.6%) tolerated the balloon throughout treatment; 87 (2.4%) declined the balloon for 1 or more treatments and tolerated the balloon for 85.5% of their treatments. Chi-square analysis revealed a significant tolerance advantage in those who received protons alone compared with combination treatment (99.5% vs. 95.7%; p < 0.001). In patients undergoing combination treatment, chi-square analysis did not reveal significant tolerance differences in patients undergoing 3D vs. 2D planning for pelvic X-ray fields (95.74% vs. 95.72%; p = 0.990).

CONCLUSIONS

Intrarectal balloons are well tolerated over a course of conformal prostate irradiation.

摘要

目的

评估在适形前列腺放疗期间使用直肠内球囊时患者的耐受性。

方法和材料

对3561例行前列腺癌适形放疗的患者进行回顾性分析。治疗包括对前列腺和精囊进行质子照射,并在必要时对骨盆进行X线治疗。记录患者耐受球囊的治疗次数。根据照射方法(单纯质子照射与质子/X线联合照射)和计划方法(联合治疗患者中X线野的二维与三维计划)对结果进行分层。

结果

在所有评估的患者中,3474例(97.6%)在整个治疗过程中耐受球囊;87例(2.4%)在1次或更多次治疗中拒绝使用球囊,其治疗中有85.5%的次数耐受球囊。卡方分析显示,单纯接受质子照射的患者与联合治疗的患者相比,耐受性有显著优势(99.5%对95.7%;p<0.001)。在接受联合治疗的患者中,卡方分析未显示在盆腔X线野进行三维与二维计划的患者之间耐受性有显著差异(95.74%对95.72%;p = 0.990)。

结论

在适形前列腺放疗过程中,直肠内球囊耐受性良好。

相似文献

1
Patient tolerance of rectal balloons in conformal radiation treatment of prostate cancer.前列腺癌适形放射治疗中患者对直肠气囊的耐受性
Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1367-70. doi: 10.1016/j.ijrobp.2005.11.001. Epub 2006 Feb 20.
2
Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization.在使用直肠内气囊进行前列腺定位和固定的剂量递增三维适形放疗(3DCRT)期间出现的急性胃肠道、泌尿生殖系统和皮肤毒性。
Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):392-6. doi: 10.1016/j.ijrobp.2004.10.003.
3
Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy.对于接受剂量递增三维适形放射治疗的患者,使用前列腺固定和直肠定位装置对直肠剂量的影响。
Urol Oncol. 2004 May-Jun;22(3):165-8. doi: 10.1016/j.urolonc.2004.02.002.
4
Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer.使用质子放疗以及单独使用直肠球囊或水治疗前列腺癌时的直肠剂量-体积差异。
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1110-6. doi: 10.1016/j.ijrobp.2007.04.075.
5
A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy.一种利用质子束放疗的部分乳腺照射技术:与适形X线放疗的比较。
Cancer J. 2007 Mar-Apr;13(2):114-8. doi: 10.1097/PPO.0b013e318046354b.
6
Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?与仅对前列腺进行适形放疗至76 Gy相比,调强适形放疗(IMRT)治疗盆腔淋巴结是否会增加直肠晚期毒性?
Strahlenther Onkol. 2006 Sep;182(9):543-9. doi: 10.1007/s00066-006-1586-9.
7
A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.一项关于优化前列腺癌放射治疗中治疗位置的II期试验。
Radiother Oncol. 2008 Jul;88(1):61-6. doi: 10.1016/j.radonc.2008.03.023. Epub 2008 Apr 29.
8
Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.使用适形避让定义的(H-CAD)调强放射治疗对前列腺低分割放疗时盆腔淋巴结剂量递增。
Acta Oncol. 2006;45(6):717-27. doi: 10.1080/02841860600781781.
9
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.对接受调强盆腔放射治疗并同时对前列腺区域进行剂量递增的高危前列腺癌患者的毒性分析。
Radiother Oncol. 2007 Aug;84(2):148-55. doi: 10.1016/j.radonc.2007.06.011. Epub 2007 Aug 9.
10
Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.使用基准剂量体积直方图在前列腺癌的三维适形放射治疗和调强放射治疗之间选择最佳技术。
Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1253-62. doi: 10.1016/j.ijrobp.2006.06.010.

引用本文的文献

1
Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.自适应放疗和前列腺癌患者计划靶区的分次内和分次间运动对剂量学的影响。
Strahlenther Onkol. 2020 Jul;196(7):647-656. doi: 10.1007/s00066-020-01596-x. Epub 2020 Mar 10.
2
Toxicity of tomotherapy-based simultaneous integrated boost in whole-pelvis radiation for prostate cancer.基于断层放疗的全盆腔同步整合加量放疗在前列腺癌治疗中的毒性反应
Yonsei Med J. 2015 Mar;56(2):510-8. doi: 10.3349/ymj.2015.56.2.510.
3
Positional reproducibility and effects of a rectal balloon in prostate cancer radiotherapy.
直肠癌放疗中直肠气囊的位置重现性和效果。
J Korean Med Sci. 2009 Oct;24(5):894-903. doi: 10.3346/jkms.2009.24.5.894. Epub 2009 Sep 24.